chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain every time he rised the arm; Arm hurting; Pain at injection site; This spontaneous case was received on 13-Nov-2020 from pharmacist via Med Communications (reference number: SEQW20-05095) and concerned a 44-year-old male patient.  The patient's concurrent conditions included allergy to sulfites. The patient's concomitant medications were not reported.  On 13-Oct-2020, the patient was vaccinated with Flucelvax QIV vaccine (influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 ml, route of administration: intramuscular, anatomical location: arm and indication: not reported). The batch number reported was 276543, expiration date: 19-Jun-2021.  On an unknown date, unknown amount of time after receiving Flucelvax QIV, the patient felt pain at injection site. As reported, the patient felt the arm hurting since he received the vaccine and had pain every time he raised the arm. No treatment measures were taken.  At the time of initial reporting on 13-Nov-2020, the patient had not recovered from the events.  The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company comment: A 44-year-old male patient was vaccinated with Flucelvax QIV. An unknown amount of time after receiving Flucelvax QIV, the patient developed vaccination site pain, pain in extremity and pain upon movement. With information available, causal role of the suspect vaccine is assessed as possibly related.; Sender's Comments: A 44-year-old male patient was vaccinated with Flucelvax QIV. An unknown amount of time after receiving Flucelvax QIV, the patient developed vaccination site pain, pain in extremity and pain upon movement. With information available, causal role of the suspect vaccine is assessed as possibly related.
Moderna COVID-19 EUA Severe fatigue, chills, lack of appetite, sore arm for 3 days, slight headache off and on Did not report to physician. Bed rest and as much fluids and  food as could tolerate. 3 doses of ibuprofen Symptoms persisted with diminishing severity until February 1, 2021
Patient reports an itchy ,erythematous, non-tender, non-indurated, non-warm  swelling  around the site if the vaccination
previously well controlled blood pressure now not controlled after 3rd Covid vaccine; has been taking rxs consistently
Tested positive for COVID, fever, encephalopathic, hypernatremia, anemia,  progressive weakness and loss of ability to walk
24 hrs. after shot, began to have chills, joint & muscle aches, serious fatigue and had a large, red, hot to touch welt at injection site. All symptoms persisted 11/7 until 11/12, when all sx's began to improve. All sx's gone by 11/15 , but
11/23/2022 Presented to the ED with high fever and evidence of severe sepsis, COVID-positive which was presumed as the main source of infection. c/o weakness and confusion, cough. erythema and warmth to the right lower leg potentially consistent with cellulitis,  given IV Rocephin Admitted with Principal Problem: COVID-19 virus infection Active Problems: Physical deconditioning not requiring oxygen at this time, will not start dexamethasone Submitter does not have access to full medical record. If additional information is needed, please contact Hospital
Generalized hives within 24 hours of DTaP administration, concurrent with URI, no fever.
Feel joint pain all over; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Feel joint pain all over) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ARTHRALGIA (Feel joint pain all over). At the time of the report, ARTHRALGIA (Feel joint pain all over) outcome was unknown.            Treatment medication not provided. Concomitant medication not provided.    This case was linked to MOD-2021-088766 (Patient Link).
PRESENTED COMPLAINING OF SWELLING, WARMTH AND RED LUMP ON LEFT THIGH AT SITE WHERE HE RECEIVED A VARIVAX.  DIAGNOSED WITH STERILE ABSCESS AND TREATED WITH BACTRIM PEDIATRIC SUSPENSION PO FOR 10 DAYS.
Arm started to swell several hours after shot until it was twice it's normal size could not move because of pain, after 3 days started itching then started benadryl slowly swelling started going doing and itching stopped after two days. Arm continued to have sharp pains for the next week
It began around 2:30 am 11/08/21 I awoke to diarrhea stomach pains and began using the toilet while I was on the toilet I began to feel nauseas. I began vomiting while still using the restroom. Once I had finished using the restroom and vomiting I began having chest pains. The chest pain would not subside and it increased when I tried to lay back down. I decided to go to the ER where they discovered and abnormal EKG and elevated troponin levels. I was given Tramadol in the ER to help with the pain and given a chest x-ray then I was checked in to a hospital room and stayed from 11/08/21-11/09/21. The doctors believed I was suffering from myocarditis or pericarditis. During my visit my blood levels were examined every few hours and my heart was monitored through an EKG. I was given morphine when my pain increased around 12 pm on 11/08/21 and then tramadol at the end of 11/08/21 when my head was throbbing. The cardiologist did an ultrasound of my heart to see if the inflammation visible on the x-ray was pericarditis or myocarditis. On 11/09/21 I was told the inflammation had decreased on its' own which lead the doctors to believe it was the result of the booster covid vaccine I received 11/05/21. The cardiologist told me I have microscopic damage to my heart muscles based on the elevated troponin levels and she believes I have pericarditis. I was released from the hospital with instructions of resting, not exercising, and eating a heart healthy diet. I have a follow up appointment with my PCP on 11/23/21 and my cardiologist said to make an appointment with her in a month. They prescribed Tramadol for me to take home in case of more chest pain in the future.
Patient reports rash on trunk and arm the was vaccinated, diarrhea, swelling at injection site
Pain/Right hand pain when woke up/Left hand affected too; Light headedness; Swelling; Right hand stiffness when woke up/Could not close her hand in morning/Left hand affected too; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Pain/Right hand pain when woke up/Left hand affected too), DIZZINESS (Light headedness), SWELLING (Swelling) and MUSCULOSKELETAL STIFFNESS (Right hand stiffness when woke up/Could not close her hand in morning/Left hand affected too) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain/Right hand pain when woke up/Left hand affected too), DIZZINESS (Light headedness), SWELLING (Swelling) and MUSCULOSKELETAL STIFFNESS (Right hand stiffness when woke up/Could not close her hand in morning/Left hand affected too). The patient was treated with PREDNISONE for Adverse event, at a dose of 1 dosage form; HYDROXYCHLOROQUINE for Adverse event, at a dose of 1 dosage form; MELOXICAM for Adverse event, at a dose of 1 UNK and IBUPROFEN for Adverse event, at a dose of 1 UNK. At the time of the report, PAIN (Pain/Right hand pain when woke up/Left hand affected too), DIZZINESS (Light headedness), SWELLING (Swelling) and MUSCULOSKELETAL STIFFNESS (Right hand stiffness when woke up/Could not close her hand in morning/Left hand affected too) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported by reporter. for mRNA-1273 (Moderna COVID-19 Vaccine) (ntramuscular), the reporter did not provide any causality assessment.    This case was linked to MOD-2021-260283 (Patient Link).
Patient presented on 2/10/06 with a total body papular vesicular rash and low grade fever. Most extremities involvement was proximal. Patient was otherwise normal. No excaberatous or crops.
Patient experienced pain, swelling, and redness at injection site immediately after vaccination. Visited urgent care on 1/28/2017 with possible infection at injection site.
Swelling and redness to left arm, proximal to MMRV injection site. Treatment - in office benadryl and ordered to take at home q6 hrs.
Pt recv vax on 11/18/98; on same day pt exp hyperemia, erythema, pain & swelling of vax site
I began have episodes of severe vertigo and dizziness 4 days post vaccination. They are unresponsive to typical medications used for vertigo.
Mother stated the same day after vaccine, pt's arm was hurting. The next day she noticed red and swollen. Dr's findings: localized reaction (swelling/erythema) 2 hours to vacc. vs. rarely cellulitis. Rx: KEFLEX 250mg/ATARAX Syrup/TYLENOL with codeine 12.5mg. Has followup appt. 10/12/10.
Dose administered after use by date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after use by date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     Medical history was not provided.    On 24-Sep-2021 at 1:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information provided by the reporter No treatment information provided by the reporter
This spontaneous report has been received from a pharmacist who heard from a nurse, regarding a 17 year old female patient. The patient's medical history and concurrent condition included an allergy to latex and penicillin G. Concomitant therapies included MENVEO and HAVRIX. On 06-SEP-2017, the patient was vaccinated with a dose of ZOSTAVAX lot number N013278 and expiration date 26-JUL-2018 (dose, frequency route of administration were not provided) for prophylaxis which was reconstituted with a sterile diluent (manufacturer unknown) instead of received a second dose of VARIVAX (frequency, route of administration, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported. There was no illness at the time of vaccination. The reporter stated that the patient was recovered from the adverse events.
This case was reported by a consumer and described the occurrence of bronchitis in a currently 91-year-old female subject who was vaccinated with Influenza vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. Historic medical conditions included sick. The subject reported that with the pneumonia vaccine (non-GSK) last year [2012] that she got sick. On an unspecified date (s) the subject received dose (s) of Influenza vaccine (details unknown). Less than one year after vaccination with Influenza vaccine, the subject experienced bronchitis, sick and cold. The subject reported that she gets sick and gets a cold that turns into bronchitis with flu shots. At the time of reporting the outcome of the events was unspecified. The patient reported events with her last flu shot. See A1050442A for details.
I got an unusual headache, not like PC headache. Tight band around head, pressure headache, not sinus, progressively got worse. Called my neurologist next day, who stated that it was likely from the vaccine in his opinion. Headache went away in about 48 hours after much sleep. MD prescribed a standard migraine medicine, which did not help.
Redness around injection site on day 2 after the vaccination got very red and warm. Pain was moderate for first 24 hours then became mild as redness intensified. Day 3 redness is lessening and area is not as warm. Effected area roughly the size of a plum.
About 16 hours after 2nd Dose of Pfizer COVID-19 vaccine, patient developed swelling, extreme discomfort, and partial loss of motion in left arm where injection was administered. Vaccine appears to have aggravated local inflammation from a pre-existing clavicle dislocation. Original clavicle dislocation possibly coincidental with Pzizer first dose (lot EP7533) in same arm.
Body aches; Tired; Mild headache; Mild swollen lymph nodes under armpit and collar bone on side of injection; Dose 1 administered on 21Feb2021 and dose 2 administered on 05Mar2021; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 05Mar2021 at 12:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 21Feb2021 at 16:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 06Mar2021, the patient experienced body aches, tired, mild headache and mild swollen lymph nodes under armpit and collar bone on side of injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, tired, mild headache and mild swollen lymph nodes under armpit and collar bone on side of injection was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Nausea; vomiting; This is a spontaneous report from a non-contactable consumer (Patient herself). A 38-year-old non-pregnant female received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6203, Expiration Date: Unknown) via an unspecified route of administration in the left arm at SINGLE DOSE for COVID-19 Immunization in the workplace clinic. The patients medical history included colitis and IBD (Inflammatory bowel disease) from an unknown date and unknown if ongoing. The patient had no allergies to medications, food or other products. Concomitant medication included Mesalamine. The patient previous received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Mar2021 for COVID-19 Immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and not tested after vaccination. The patient experienced nausea and vomiting approximately 22 hours and again 28 hours after receiving vaccine on 25Mar2021 at 08:00.   Follow-up action is closed, further information is cannot be obtained.
maculo-papular rash on left thigh at site of injection. some itch. no other symptoms. per phone call on 1/9/2023, rash is still the same, not extending past the thigh area
Patient has been feeling ill with persisting nausea, headaches, malaise, generalized abdominal pain.  She has intermittent shortness of breath with chest discomfort.  She is not sure if this related to panic attacks.  For the last 3 days she has had left posterior neck pain with radiation of pain to her head and left upper and lower arm.  Her left arm feels numb and limp at times.  She received the vaccine in her left arm.
Within 10 min. of injection, he became nauseated and weak.Another min. or 2 and he fell asleep. He was difficult to rouse only a min. later and he broke out into a sweat, his cheeks flushed and his eyes were red and very glassy. We rushed to ER. Breathing was very shallow, he was non-responsive and within 15 min, he was broken out in hives all over body, soon hives looked like blisters. Dr. administered Benadryl and Tylenol with no effect. Injection of steroids showed results within minutes. Hives were no longer apparent but he was agitated and crying the rest of the day. Next day, he seems in good health as he was previously.
Patient called PDDH on 10/27/08 and informed nurse her shoulder has been aching since she received flu shot 3 weeks ago. Instructed her to f/u with her physician.
Patient reports metallic taste and tightness in throat for up to 10 minutes.  Cleared by EMS
After I received the first shot, an itchy rash began to appear all over my body.  When getting the second shot, I showed the person administering the shot and asked if I should get the second shot and she said that it would be okay.  This rash has continued to plaque me ever since.  I went to my primary care and she referred me to an allergist, Dr. He has run a number of tests and determined that I do not have an allergy.  I have an appointment with a dermatologist on Sept. 23, 2021.  I am 74 years old and never experienced anything like this my whole life.  No one can determine where I got this or how to treat it.  First it was hives, then told it was exzema.
Pt given Covid 19 Bivalent vaccine .Pt had previously received one on 10/13/22
Information has been received from a male consumer referring to his mother, a female patient of unknown age. The patient's medical history, concurrent condition and concomitant medication were not reported. At an unspecified time, the patient received the first dose of PNEUMOVAX 23 (lot #, expiration date, dose and route unknown) at an unspecified location. Four weeks after the first PNEUMOVAX 23 vaccine, the patient was administered a second PNEUMOVAX 23 vaccine at an unspecified hospital. It could not be confirmed how, when, why, or for how long the patient was at the hospital to receive the second dose of PNEUMOVAX 23, therefore a complete adverse event report was completed. It was reported that the patient did not seek medical attention. The outcome of the event was unknown. The causal relationship between the event and PNEUMOVAX 23 was not reported. Additional information is not expected as the reporter declined to supply any demographic data for the patient or the patient's physician.
Pt. was vaccinated by student nurse who was under clinical supervision by nursing instructor. Pt states her arm started hurting immediately after shot given, and that shot was into shoulder joint not deltoid. Limited ROM post vaccination.
Patient Daughter called and said pt. had a very bad reaction to her Shingrix shot. Her shot was friday. She had a fever of over 102. flu like symptoms , body aches, nausea, weakness. She was in bed all day yesterday and when she got up out of bed, she passed out . Her daughter reported that she was incontinent because of her passing out. She is extrememly nauseous today also and very weak.
This spontaneous report was received from a 58 year old female patient. Patient's medical history, concurrent conditions and concomitant medications were not reported. In approximately 2010, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dosing details not provided). Subsequently, on an unspecified date, the patient experienced an unspecified reaction at the injection site. The outcome of the event was unknown at the time of report. Causality assessment was not provided. No further information provided. Additional information is not expected as no contact details were provided.
Information has been received from a physician concerning a 17 yr old male who in Sept 2004, was vaccinated with a 0.5ml dose of varicella virus vaccine live (lot647761/0097P). In varicella virus vaccine live (lot647761/0097P). In Sep2004, soon after the shot, the pt experienced a stiff neck, headache and fever. Unspecified medical attention was sought. The outcome is unk. No product quality complaint was involved. Additional information has been requested.
Two days post vax, the pt presented with extreme swelling and redness of right arm from shoulder to elbow. Pt appeared to have cellulitis in tricep region of arm that required antibiotics to treat the inflammation.
Information has been received from an office manager concerning a 76 year old female who on 10-FEB-2009 was subcutaneously vaccinated with a dose of ZOSTAVAX (Merck). On 10-FEB-2009 the patient developed a hard and hot lump the size of silver dollar at the injection site. The next day she started sneezing and coughing. She recovered one week after receiving ZOSTAVAX (Merck). The patient sought unspecified medical attention. Follow up information was received from a health professional concerning the patient with no illness at time of vaccination who was subcutaneously vaccination with the first dose of ZOSTAVAX (Merck) (lot #662855/1623X) at 15:30 on 02-FEB-2009 (previously reported as 10-FEB-2009) in the left arm. On 02-FEB-2009 (previously reported as 10-FEB-2009) the patient had a red spot on arm with size of a silver dollar. There was no pain. Then about 3 days after injection, on 05-FEB-2009 approximately, the patient got an upper respiratory infection. Additional information has been requested.